PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 8 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Incorporation of P. esculentus in feed resulted in a significant decrease in hyperglycemia, reduction of glycated hemoglobin (HbA1C), and amelioration of elevated urinary protein, sugars, and specific gravity [PMID:25349824, PMID:28962281]. It also improved lipid profiles by reducing triglycerides, total cholesterol, LDL, and VLDL [PMID:28962281].
Intake of P. esculentus resulted in significant amelioration of hepatic glucose-6-phosphate dehydrogenase (G6PD) activities in streptozotocin-induced diabetic rats [PMID:25076344].
Methanol extract of P. esculentus tuber and its fractions were evaluated for their effect on relative prostate weights (RPW) and prostate specific antigen (PSA) [PMID:38735419].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38735419 (2024) — Effect of methanol extract of Plectranthus esculentus N.E.Br tuber and its fractions on indices of benign prostatic hyperplasia in Wistar rats. · Journal of ethnopharmacology
- 2.PMID: 25076344 (2014) — Effect of Livingstone potato (Plectranthus esculentus N.E.Br) on hepatic glucose-6-phosphophate dehydrogenase activity of streptozotocin induced diabetic rats. · JOP : Journal of the pancreas
- 3.PMID: 35614331 (2022) — Belgian endive-derived biostimulants promote shoot and root growth in vitro. · Scientific reports
- 4.PMID: 25349824 (2014) — Effect of Livingstone Potato (Plectranthus esculenthus N.E.Br) on Diabetes and Its Complications in Streptozotocin Induced Diabetes in Rats. · Diabetes & metabolism journal
- 5.PMID: 38181991